GeoVax Labs, Inc. (GOVX) stock
GOVXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.71−0.33 (-16.42%)
Close on Nov 13, 2026Market cap $717.73KP/E –Yield –
GeoVax Labs profit margin
Profit margin (net margin) is net income as a percentage of revenue.
GeoVax Labs's profit margin for the twelve months ending Mar 31, 2026 was -2507.3%. For fiscal 2025 it was -862.3%, against -632.0% the year before. The highest annual figure on record is -162.2% in fiscal 2020.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -862.3% | −230.4 |
| FY2024 | Dec 31, 2024 | -632.0% | +16566.4 |
| FY2022 | Dec 31, 2022 | -17198.3% | −12381.2 |
| FY2021 | Dec 31, 2021 | -4817.2% | −4655.0 |
| FY2020 | Dec 31, 2020 | -162.2% | +39.4 |
| FY2019 | Dec 31, 2019 | -201.6% | +64.2 |
| FY2018 | Dec 31, 2018 | -265.8% | −64.0 |
| FY2017 | Dec 31, 2017 | -201.8% | +192.9 |
| FY2016 | Dec 31, 2016 | -394.7% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2025 | Jun 30, 2025 | -630.0% | +1054.2 |
| Q1 FY2025 | Mar 31, 2025 | -327.3% | +2650.3 |
| Q4 FY2024 | Dec 31, 2024 | -955.9% | +7375.1 |
| Q3 FY2024 | Sep 30, 2024 | -208.5% | +6204.7 |
| Q2 FY2024 | Jun 30, 2024 | -1684.2% | −35.7 |
| Q1 FY2022 | Mar 31, 2022 | -2977.6% | −1562.3 |
| Q4 FY2021 | Dec 31, 2021 | -8331.0% | −7799.8 |
| Q3 FY2021 | Sep 30, 2021 | -6413.2% | −6275.8 |
| Q2 FY2021 | Jun 30, 2021 | -1648.6% | −1545.2 |
| Q1 FY2021 | Mar 31, 2021 | -1415.3% | −1332.1 |
| Q4 FY2020 | Dec 31, 2020 | -531.2% | −311.2 |
| Q3 FY2020 | Sep 30, 2020 | -137.4% | −10.0 |
| Q2 FY2020 | Jun 30, 2020 | -103.3% | +208.3 |
| Q1 FY2020 | Mar 31, 2020 | -83.2% | +109.4 |
| Q4 FY2019 | Dec 31, 2019 | -219.9% | −8.0 |
| Q3 FY2019 | Sep 30, 2019 | -127.4% | +63.5 |
| Q2 FY2019 | Jun 30, 2019 | -311.6% | +371.5 |
| Q1 FY2019 | Mar 31, 2019 | -192.6% | +88.4 |
| Q4 FY2018 | Dec 31, 2018 | -211.9% | +75.8 |
| Q3 FY2018 | Sep 30, 2018 | -190.9% | +46.5 |
| Q2 FY2018 | Jun 30, 2018 | -683.0% | −536.3 |
| Q1 FY2018 | Mar 31, 2018 | -281.0% | −95.6 |
| Q4 FY2017 | Dec 31, 2017 | -287.7% | – |
| Q3 FY2017 | Sep 30, 2017 | -237.4% | – |
| Q2 FY2017 | Jun 30, 2017 | -146.8% | – |
| Q1 FY2017 | Mar 31, 2017 | -185.4% | – |
See a number that looks wrong?